Search Results
You are looking at 1 - 3 of 3 items for
- Author: Hitoshi Suzuki x
- Refine by access: All content x
Search for other papers by Hayato Shimada in
Google Scholar
PubMed
Search for other papers by Hitoshi Okamura in
Google Scholar
PubMed
Search for other papers by Yōichi Noda in
Google Scholar
PubMed
Search for other papers by Akira Suzuki in
Google Scholar
PubMed
Search for other papers by Shimpei Tōjō in
Google Scholar
PubMed
Search for other papers by Akikazu Takada in
Google Scholar
PubMed
To elucidate the possible roles of increased plasminogen activator (PA) in follicular rupture and to investigate whether prostaglandins participate in ovarian PA synthesis in vivo, enzyme activities were sequentially measured by a method using the chromogenic substrate S-2251 in immature rat ovaries primed with pregnant mare serum gonadotrophin (PMSG) followed by human chorionic gonadotrophin (hCG) either alone or with a concurrent injection of indomethacin.
Before hCG injection PA activity was 0·006 ± 0·006 (s.d.) μmol/1·6 mg ovarian tissue (wet wt) per 30 min: PA activity of a saline-treated group remained at low levels (<0·018 ± 0·003 μmol/1·6 mg tissue per 30 min). In contrast, PA activity of animals given hCG alone increased after the treatment, reaching a peak value of 0·112 ± 0·071 μmol/1·6 mg tissue per 30 min 12 h later, before decreasing to 0·023 ± 0·014 μmol/1·6 mg tissue per 30 min at 32 h. Contrary to expectations, a dose of indomethacin which completely blocked ovulation had no effect on either the magnitude or the time-course of PA synthesis after hCG administration (P>0·05).
These results indicate that prostaglandins are not involved in the preovulatory synthesis of PA induced by hCG in rat ovaries and that PA is not a primary proteolytic enzyme for follicular rupture. It is suggested that PA has possible roles in cumulus detachment and/or proliferation of granulosa cells during the ovulatory process.
Departments of, Physiology, Otorhynolaryngology, Department of Physiology, Section on Neural Gene Expression, Department of Cellular Neurophysiology, Department of Anatomy and Neurobiology, Molecular Neuroendocrinology Research Group, School of Medicine, University of Occupational and Environmental Health, 1-1 Iseigaoka, Yahatanishi-ku, Kitakyushu 807-8555, Japan
Search for other papers by Akiko Katoh in
Google Scholar
PubMed
Search for other papers by Hiroaki Fujihara in
Google Scholar
PubMed
Departments of, Physiology, Otorhynolaryngology, Department of Physiology, Section on Neural Gene Expression, Department of Cellular Neurophysiology, Department of Anatomy and Neurobiology, Molecular Neuroendocrinology Research Group, School of Medicine, University of Occupational and Environmental Health, 1-1 Iseigaoka, Yahatanishi-ku, Kitakyushu 807-8555, Japan
Search for other papers by Toyoaki Ohbuchi in
Google Scholar
PubMed
Search for other papers by Tatsushi Onaka in
Google Scholar
PubMed
Search for other papers by W Scott Young III in
Google Scholar
PubMed
Search for other papers by Govindan Dayanithi in
Google Scholar
PubMed
Search for other papers by Yuka Yamasaki in
Google Scholar
PubMed
Search for other papers by Mitsuhiro Kawata in
Google Scholar
PubMed
Search for other papers by Hitoshi Suzuki in
Google Scholar
PubMed
Search for other papers by Hiroki Otsubo in
Google Scholar
PubMed
Search for other papers by Hideaki Suzuki in
Google Scholar
PubMed
Search for other papers by David Murphy in
Google Scholar
PubMed
Search for other papers by Yoichi Ueta in
Google Scholar
PubMed
We have generated rats bearing an oxytocin (OXT)-enhanced cyan fluorescent protein (eCFP) fusion transgene designed from a murine construct previously shown to be faithfully expressed in transgenic mice. In situ hybridisation histochemistry revealed that the Oxt–eCfp fusion gene was expressed in the supraoptic nucleus (SON) and the paraventricular nucleus (PVN) in these rats. The fluorescence emanating from eCFP was observed only in the SON, the PVN, the internal layer of the median eminence and the posterior pituitary (PP). In in vitro preparations, freshly dissociated cells from the SON and axon terminals showed clear eCFP fluorescence. Immunohistochemistry for OXT and arginine vasopressin (AVP) revealed that the eCFP fluorescence co-localises with OXT immunofluorescence, but not with AVP immunofluorescence in the SON and the PVN. Although the expression levels of the Oxt–eCfp fusion gene in the SON and the PVN showed a wide range of variations in transgenic rats, eCFP fluorescence was markedly increased in the SON and the PVN, but decreased in the PP after chronic salt loading. The expression of the Oxt gene was significantly increased in the SON and the PVN after chronic salt loading in both non-transgenic and transgenic rats. Compared with wild-type animals, euhydrated and salt-loaded male and female transgenic rats showed no significant differences in plasma osmolality, sodium concentration and OXT and AVP levels, suggesting that the fusion gene expression did not disturb any physiological processes. These results suggest that our new transgenic rats are a valuable new tool to identify OXT-producing neurones and their terminals.
Department of Physiology, Laboratory of Physiology, Department of Urology, School of Medicine, University of Occupational and Environmental Health, Kitakyushu 807-8555, Japan
Search for other papers by Hiroki Otsubo in
Google Scholar
PubMed
Search for other papers by Susumu Hyodo in
Google Scholar
PubMed
Search for other papers by Hirofumi Hashimoto in
Google Scholar
PubMed
Search for other papers by Makoto Kawasaki in
Google Scholar
PubMed
Search for other papers by Hitoshi Suzuki in
Google Scholar
PubMed
Search for other papers by Takeshi Saito in
Google Scholar
PubMed
Search for other papers by Toyoaki Ohbuchi in
Google Scholar
PubMed
Search for other papers by Toru Yokoyama in
Google Scholar
PubMed
Search for other papers by Hiroaki Fujihara in
Google Scholar
PubMed
Search for other papers by Tetsuro Matsumoto in
Google Scholar
PubMed
Search for other papers by Yoshio Takei in
Google Scholar
PubMed
Search for other papers by Yoichi Ueta in
Google Scholar
PubMed
We examined the effects of i.c.v. administration of adrenomedullin 5 (AM5) on the brain of conscious rats. We used porcine AM5 in the present study because rat AM5 has not been detected. We observed Fos-like immunoreactivity (LI) in the hypothalamus and brainstem of conscious rats after i.c.v. administration of AM5 (2 nmol/rat). Fos-LI, measured at 90 min post-AM5 injection, was observed in various brain areas, including the supraoptic (SON) and the paraventricular nuclei (PVN). Dual immunostaining for Fos/oxytocin (OXT) and Fos/arginine vasopressin (AVP) revealed that OXT-LI neurones predominantly colocalized Fos-LI compared with AVP-LI neurones in the SON and the PVN. Plasma OXT levels were significantly increased 5 min after i.c.v. administration of AM5 (1 nmol/rat) compared with vehicle and remained elevated in samples taken at 15 and 30 min without changes in plasma AVP levels at any time. In situ hybridization histochemistry showed that i.c.v. administration of AM5 (0.2, 1 and 2 nmol/rat) caused a marked induction of the expression of the c-fos gene in the SON and the PVN. This induction was significantly but not completely reduced by pretreatment with both the calcitonin gene-related peptide (CGRP) antagonist CGRP-(8–37; 3 nmol/rat) and the AM receptor antagonist AM-(22–52; 27 nmol/rat). Although porcine AM5 has not been detected yet in the brain, these results suggest that centrally administered porcine AM5 may activate OXT-secreting neurosecretory cells in the hypothalamus partly through AM/CGRP receptors and elicit secretion of OXT into the systemic circulation in conscious rats.